Metabolomic analysis using glioma cell lines and surgical specimens indicated significantly reduced levels of glutamate in IDH-mutant gliomas [19,20,21,22], as glutamate used to produce α-KG is now used to synthesize 2-HG. The gene discussed is IDH2; the disease is central nervous system cancer.